Analyst
Lake Street Capital Markets
Equibles does not estimate personal net worth.
Nelson Cox is recorded as Analyst at Lake Street Capital Markets. Nelson Cox has spoken on 6 earnings calls across 4 companies, most recently for Stereotaxis, Inc. on August 11, 2026. Those appearances were for Hyperfine, Inc. (HYPR), TriSalus Life Sciences, Inc. (TLSI), Stereotaxis, Inc. (STXS) and Sight Sciences, Inc. (SGHT). The companies whose calls Nelson Cox spoke on are classified in the Healthcare sector.
“I wanted to start with the U.S. Genesis X purchase. On the compatibility strategy, once you declare formal compatibility with that first x-ray manufacturer with the fall install, what's the path to other major OEMs?”
“In the past, you've talked about budgetary cycles for the IDN initiatives and the back half kind of lining up with that. So you have $7.8 million on the board in the first half, and then the guidance assumes around $12 to $14 million in the second half.”
“I wanted to start with the dry eye business. You nearly doubled your active accounts this quarter and I had a nice step up in utilization. Last quarter, I think you mentioned something about a handful of accounts.”
“Maybe just start with the IDNs and the multi-unit. ordering a bit more, can you maybe talk a little bit more about the typical decision criteria and timelines you're seeing there and how many of these IDN conversations are at that standardization stage versus kind of the single site pilots?”
“I want to start with 2026. understand you guys are not batting for that today, but just any color you feel comfortable providing there in terms of how we should be thinking about growth in 2026.”
Lake Street Capital Markets
Analyst
Source not stated
HYPR
Medical Devices · Healthcare
STXS
Medical Instruments & Supplies · Healthcare
SGHT
Medical Devices · Healthcare
